Location: Lisbon, Portugal
Date: May 5 to May 8
86th European Atherosclerosis Society, Cardiology conference.
Early therapy versus late intervention: What works?
Strategies to treat vulnerable plaques
The Netherlands The role of bile acids in cholesterol homeostasis
Neoatherosclerosis from a pathologist's point of view
Familial chylomicronemia syndrome (FCS)
Will inhibiting of thrombus formation prevent acute coronary syndromes?
Disturbances in hepatic and lipoprotein metabolism is the hallmark of atherogenic dyslipidaemia
Lifestyle and genetics an interaction contributing to CV risk
The latest practical considerations in treating blood cholesterol levels in coronary patients - State of the art lipid lowering combination therapies
Should the main target behyperglycaemia or should we focus on other risk-factors?
Stress, behavior and cardiovascular disease
Is there need to revise goals from lipid lowering?
High-resolution lipoprotein phenotypes and cardiovascular outcomes
Cardioprotection in type 2 diabetes: is the picture clear or not?
Anti-inflammatory therapy and resolution of inflammation, theory and practice